Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
2 intermediate papers

Works of Robert L. Campbell being referenced

Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies
2018
PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura
2017

Author Peers

Author Last Decade Papers Cites
Robert L. Campbell 264 128 192 138 28 763
Jerry Oakes 282 95 224 279 29 708
Jerry M.E. Kovoor 232 195 153 76 45 763
Michael J. Bresnan 162 112 167 64 34 713
William O. Bell 267 36 163 142 27 749
Donald H. Reigel 343 148 270 353 34 957
Brian P. Brophy 230 95 293 66 53 743
Carl A. Geyer 383 97 207 274 22 842
Sidney Carter 115 87 247 55 29 745
E. Andrew Stevens 246 136 257 85 35 734
Gregg N. Dyste 348 127 179 391 17 851

All Works

Loading papers...

Rankless by CCL
2026